Rx Medicare

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated a Phase 2b clinical trial with AZ-104 (Staccato loxapine) in patients with migraine headaches. AZ-104 is a lower-dose version of AZ-004 (Staccato loxapine), Alexza’s lead product candidate that is in late Phase 3 clinical development for the acute treatment of agitation in patients with schizophrenia or bipolar disorder.

Read More…

Related Posts

• MAP Pharmaceuticals Announces Completion Of Enrollment In Phase 3 Clinical Trial Of MAP0004 In Patients With Migraine
• Phase IIa Clinical Trial Results Relating To CK-1827452 In Patients With Ischemic Cardiomyopathy And Angina
• Amarillo Biosciences Announces Australian Phase 2 Oral Interferon Clinical Trial Indicates Benefit In Preventing Influenza-Like Illness In Seniors
• Trigemina Conducting Phase IIa Clinical Trial In Chronic Daily Headache
• Winston Laboratories, Inc. Announces Positive Top-line Results Of Phase II Clinical Trial Of Civamide Patch
• MAP Pharmaceuticals Phase 3 Trial Of Levadex? Migraine Product Candidate Meets All Four Primary Endpoints
• MAP Pharmaceuticals Phase 3 Trial Of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
• NanoBio Initiates FDA Approved Clinical Trial For Adjuvanted Intranasal Influenza Vaccine
• PAION Initiates Phase II Trial With Its Anesthetic/Sedative CNS 7056
• Cerimon Pharmaceuticals Initiates Phase III Clinical Studies To Evaluate Its Topical Diclofenac Sodium Patch For Mild-to-Moderate Pain
• Addex Starts A Phase IIb Trial Of ADX10059 For Migraine Prevention
• Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of … – PR Newswire (press release)
• Repros Thera. Announces That Proellex Significantly Reduced Pain In A U.S. Phase 2 Clinical Trial In Women With Moderate To Severe Endometriosis
• Telcagepant Proven As A Safe And Effective Migraine Treatment In Phase III Trial
• Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine

Tags: alexza, clinical, headaches, initiates, loxapine, migraine, patients, phase, staccator, trial

This entry was posted on Saturday, January 24th, 2009 at 8:01 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.